The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation

Antimicrobial Agents and Chemotherapy
Emily LarkinMahmoud Ghannoum

Abstract

Candidaauris, a new multidrug-resistant Candida spp. which is associated with invasive infection and high rates of mortality, has recently emerged. Here, we determined the virulence factors (germination, adherence, biofilm formation, phospholipase and proteinase production) of 16 C. auris isolates and their susceptibilities to 11 drugs belonging to different antifungal classes, including a novel orally bioavailable 1,3-β-d-glucan synthesis inhibitor (SCY-078). We also examined the effect of SCY-078 on the growth, ultrastructure, and biofilm-forming abilities of C. auris Our data showed that while the tested strains did not germinate, they did produce phospholipase and proteinase in a strain-dependent manner and had a significantly reduced ability to adhere and form biofilms compared to that of Candida albicans (P = 0.01). C. auris isolates demonstrated reduced susceptibility to fluconazole and amphotericin B, while, in general, they were susceptible to the remaining drugs tested. SCY-078 had an MIC90 of 1 mg/liter against C. auris and caused complete inhibition of the growth of C. auris and C. albicans Scanning electron microscopy analysis showed that SCY-078 interrupted C. auris cell division, with the organism forming abnorma...Continue Reading

References

Jan 1, 1992·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·J M SmithA C Pier
Jan 1, 1980·Annual Review of Microbiology·M R McGinnis
Mar 1, 1994·Infection and Immunity·S P Hawser, L J Douglas
May 14, 1998·Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology·M A Ghannoum
Jan 11, 2000·Clinical Microbiology Reviews·M A Ghannoum
Dec 3, 2002·Nature Reviews. Genetics·Judith Berman, Peter E Sudbery
Mar 29, 2003·Diagnostic Microbiology and Infectious Disease·Emilia CantónAna Espinel-Ingroff
Oct 7, 2004·Applied and Environmental Microbiology·Ray J Emerson, Terri A Camesano
Sep 26, 2006·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Ann R HolmesPatrick Dawes
Jan 15, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·UNKNOWN Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility T
Jan 31, 2009·Nature Protocols·Jyotsna ChandraMahmoud A Ghannoum
Feb 6, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mi-Na KimDong Wook Ryang
Aug 18, 2009·Journal of Visualized Experiments : JoVE·Carrie Cupp-Enyard
Nov 19, 2009·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Gillian RodgerJoanna Verran
Apr 23, 2010·The New Phytologist·Kessy AbarenkovUrmas Kõljalg
Nov 10, 2010·Antimicrobial Agents and Chemotherapy·Fernando C BizerraArnaldo L Colombo
Dec 9, 2010·The Journal of Antimicrobial Chemotherapy·Aspasia KatragkouEmmanuel Roilides
Jul 1, 2011·Journal of Clinical Microbiology·Wee Gyo LeeHee-Chang Jang
Apr 13, 2012·PLoS Pathogens·Saranna Fanning, Aaron P Mitchell
Aug 2, 2013·Proceedings of the National Academy of Sciences of the United States of America·Ahmed FazlyPaul D Kaufman
Sep 21, 2013·Emerging Infectious Diseases·Anuradha ChowdharyJacques F Meis
Dec 21, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A ChowdharyJ F Meis
Jun 26, 2014·Emerging Infectious Diseases·Rindidzani E MagoboNelesh P Govender
Dec 17, 2014·Intensive Care Medicine·Arunaloke ChakrabartiDeepak Mendiratta
Apr 18, 2015·Journal of Infection in Developing Countries·Dharmendra KumarRagini Tilak
May 20, 2015·Emerging Infectious Diseases·Maha EmaraRitu Bafna
Mar 11, 2016·Pathogens and Disease·Christina TsuiMary Ann Jabra-Rizk
Jun 16, 2016·Journal of Pain & Palliative Care Pharmacotherapy· Centers For Disease Control And Prevention Public Health Service U S Department Of Health And Human Services
Jul 28, 2016·The Journal of Infection·Belinda CalvoArnaldo Lopes Colombo
Oct 26, 2016·Antimicrobial Resistance and Infection Control·Silke SchelenzMatthew C Fisher
Dec 17, 2016·Emerging Infectious Diseases·Soraya E Morales-LópezJosé Y Rodríguez

❮ Previous
Next ❯

Citations

Jul 8, 2017·Mycoses·Jalila MohsinAbdullah M S Al-Hatmi
Oct 14, 2017·The Journal of Antimicrobial Chemotherapy·Marjan M HashemiPaul B Savage
Feb 9, 2018·Journal of Fungi·Jonathan P RichardsonJulian R Naglik
Jan 27, 2018·Journal of Fungi·Ryan KeanGordon Ramage
May 16, 2018·Annals of the New York Academy of Sciences·Jennifer Geddes-McAlister, Rebecca S Shapiro
Nov 22, 2017·Antimicrobial Agents and Chemotherapy·Ruvini U PathiranaMira Edgerton
Nov 8, 2017·Expert Review of Anti-infective Therapy·Matthew William McCarthy, Thomas J Walsh
Nov 17, 2017·Clinical Microbiology Reviews·Anna Jeffery-SmithColin S Brown
Jun 8, 2018·Current Opinion in Infectious Diseases·Katja SarisAndreas Voss
Nov 15, 2017·Antimicrobial Agents and Chemotherapy·Jyotsna Chandra, Mahmoud A Ghannoum
Nov 24, 2017·Journal of Clinical Microbiology·Emily S Spivak, Kimberly E Hanson
Aug 18, 2018·Journal of Fungi·Ronen Ben-Ami
Jul 28, 2018·Environmental Microbiology·Eric KuhnertGerald F Bills
Aug 30, 2017·Antimicrobial Agents and Chemotherapy·Hamed FakhimHamid Badali
May 10, 2017·Antimicrobial Agents and Chemotherapy·Elizabeth L BerkowShawn R Lockhart
Oct 4, 2018·The New England Journal of Medicine·David W EyreKatie J M Jeffery
Nov 21, 2017·F1000Research·Anna SkiadaMaria Drogari-Apiranthitou
Jun 14, 2018·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Yuman LeeSagar Viramgama
Jan 27, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mohammad H SemreenAshraf S Ibrahim
Dec 12, 2018·Antimicrobial Agents and Chemotherapy·Nathan P WiederholdThomas F Patterson
Apr 9, 2019·PLoS Pathogens·Jeniel E Nett
Nov 22, 2017·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jennifer L CadnumCurtis J Donskey
May 23, 2019·Journal of Occupational and Environmental Hygiene·Steven R TorresMagdia De Jesus
Oct 25, 2017·Nature Reviews. Microbiology·William O C M CooksonMiriam F Moffatt
Feb 19, 2019·Mycoses·Shabir A Lone, Aijaz Ahmad
Jul 5, 2019·Journal of Medical Microbiology·David RomeraJaime Esteban
Jul 22, 2019·The Journal of Antimicrobial Chemotherapy·Shivaprakash M RudramurthyArunaloke Chakrabarti
Jul 26, 2019·Medical Mycology·M R DavisG R Thompson
Jul 25, 2019·Journal of Fungi·Daniel Z P Friedman, Ilan S Schwartz
Aug 6, 2019·PLoS Pathogens·Shakti SinghAshraf S Ibrahim
Jun 16, 2017·Expert Opinion on Investigational Drugs·Matthew W McCarthy, Thomas J Walsh
Aug 8, 2017·Expert Review of Anti-infective Therapy·Bhagyashri D NavalkelePranatharthi Chandrasekar
Oct 28, 2019·Current Topics in Medicinal Chemistry·Laura Nunes SilvaAndré Luis Souza Dos Santos
Mar 7, 2020·Chemical Society Reviews·Kaitlind C HowardSylvie Garneau-Tsodikova
Mar 1, 2020·Journal of Fungi·Ryan KeanGordon Ramage
Apr 3, 2020·Expert Review of Anti-infective Therapy·Arunaloke Chakrabarti, Shreya Singh

❮ Previous
Next ❯

Datasets Mentioned

BETA
KY514262

Methods Mentioned

BETA
scanning electron microscopy
Proteinase assay

Software Mentioned

Vitek
GraphPad Prism
R
BLAST

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Related Papers

Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia
M RomeroM Gobernado
Emerging Infectious Diseases
Leighann SherryRiina Rautemaa-Richardson
© 2021 Meta ULC. All rights reserved